Quarterly report · Q2
8095.TEDINET S100OPJO
Period2021-12-01 → 2022-05-31
Filed2022-07-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥24.9bn | 2021-12-01 → 2022-05-31 | Cons. | Net sales |
| Revenue | ¥72.3bn | 2020-12-01 → 2021-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥36.2bn | 2020-12-01 → 2021-05-31 | Cons. | Net sales |
| Operating income | ¥720m | 2021-12-01 → 2022-05-31 | Cons. | Operating income |
| Operating income | ¥1.5bn | 2020-12-01 → 2021-05-31 | Cons. | Operating income |
| Ordinary income | ¥835m | 2021-12-01 → 2022-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.4bn | 2020-12-01 → 2021-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2020-12-01 → 2021-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.5bn | 2021-12-01 → 2022-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.6bn | 2020-12-01 → 2021-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥933m | 2021-12-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.7bn | 2020-12-01 → 2021-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥976m | 2020-12-01 → 2021-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥928m | 2021-12-01 → 2022-05-31 | Cons. | Profit loss |
| Net income | ¥976m | 2020-12-01 → 2021-05-31 | Cons. | Profit loss |
| Total assets | ¥63.9bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥63.6bn | at 2021-11-30 | Cons. | Assets |
| Total assets | ¥60.3bn | at 2021-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥36.0bn | at 2022-05-31 | Cons. | Liabilities |
| Total liabilities | ¥36.5bn | at 2021-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥27.8bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥27.0bn | at 2021-11-30 | Cons. | Net assets |
| Net assets / equity | ¥25.4bn | at 2021-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.4bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.9bn | at 2021-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.3bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2021-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.9bn | at 2021-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.4bn | at 2020-11-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.3bn | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2020-12-01 → 2021-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥23m | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.4bn | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.5bn | 2020-12-01 → 2021-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.9bn | 2021-12-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.4bn | 2020-12-01 → 2021-11-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.6bn | 2020-12-01 → 2021-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥23.33 | 2021-12-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.08 | 2022-03-01 → 2022-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.86 | 2020-12-01 → 2021-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.06 | 2020-12-01 → 2021-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.06 | 2021-03-01 → 2021-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥46.63 | 2020-12-01 → 2021-11-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.76 | 2020-12-01 → 2021-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 43.5% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2021-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.1% | at 2021-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 57
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-12-01 → 2022-05-31 | ¥807,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-12-01 → 2022-05-31 | ¥807,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-12-01 → 2022-05-31 | −¥19m |
| Reconciling Itemsreconciling | revenue | 2021-12-01 → 2022-05-31 | −¥740m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-12-01 → 2022-05-31 | −¥740m |
| Reconciling Itemsreconciling | segment profit | 2021-12-01 → 2022-05-31 | ¥17m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥7.9bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥7.5bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥348m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-05-31 | ¥474m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥7.3bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥7.2bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥105m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2021-12-01 → 2022-05-31 | −¥66m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥4.4bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥4.3bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥52m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2021-12-01 → 2022-05-31 | −¥38m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2021-12-01 → 2022-05-31 | ¥6.1bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2021-12-01 → 2022-05-31 | ¥5.9bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥235m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2021-12-01 → 2022-05-31 | ¥353m |
| —segment total | revenue | 2021-12-01 → 2022-05-31 | ¥25.7bn |
| —segment total | revenue external | 2021-12-01 → 2022-05-31 | ¥24.9bn |
| —segment total | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥740m |
| —segment total | segment profit | 2021-12-01 → 2022-05-31 | ¥722m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-12-01 → 2022-05-31 | ¥25.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-12-01 → 2022-05-31 | ¥24.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-12-01 → 2022-05-31 | ¥740m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-12-01 → 2022-05-31 | ¥704m |
| Reconciling Itemsreconciling | revenue | 2020-12-01 → 2021-05-31 | −¥641m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-12-01 → 2021-05-31 | −¥641m |
| Reconciling Itemsreconciling | segment profit | 2020-12-01 → 2021-05-31 | −¥10m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2020-12-01 → 2021-05-31 | ¥12.1bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2020-12-01 → 2021-05-31 | ¥11.6bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥500m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2020-12-01 → 2021-05-31 | ¥726m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2020-12-01 → 2021-05-31 | ¥14.0bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2020-12-01 → 2021-05-31 | ¥14.0bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥4m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2020-12-01 → 2021-05-31 | −¥350m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2020-12-01 → 2021-05-31 | ¥4.1bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2020-12-01 → 2021-05-31 | ¥4.1bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥36m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2020-12-01 → 2021-05-31 | ¥206m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2020-12-01 → 2021-05-31 | ¥6.6bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2020-12-01 → 2021-05-31 | ¥6.5bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥102m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2020-12-01 → 2021-05-31 | ¥923m |
| —segment total | revenue | 2020-12-01 → 2021-05-31 | ¥36.9bn |
| —segment total | revenue external | 2020-12-01 → 2021-05-31 | ¥36.2bn |
| —segment total | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥641m |
| —segment total | segment profit | 2020-12-01 → 2021-05-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-12-01 → 2021-05-31 | ¥36.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-12-01 → 2021-05-31 | ¥36.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-12-01 → 2021-05-31 | ¥641m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-12-01 → 2021-05-31 | ¥1.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 638
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)ＰｗＣあらた有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)塩谷 岳志 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)五代 英紀 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 36249985000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 24934991000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 72322233000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 1573957000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 835016000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 2420877000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 975817000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 932969000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 1736962000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 999603000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 920799000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 1752866000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 25399127000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 27829897000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 27006272000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 60302933000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 63871453000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 63553650000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 28.06 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 23.33 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 46.86 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 27.76 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 46.63 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.421 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.435 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.425 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 1293786000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 1328828000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1349233000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -2524404000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -22888000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -4380002000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 4605614000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -1901195000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 6353182000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 10861484000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 10261123000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 10807061000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 16.06 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 12.08 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 40772366 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 40772366 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 40772366 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 40772366 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |